The principal advantage of insulin Glargine over neutral protamine Hagedorn ( NPH) insulin is in a lower frequency of hypoglycemic reactions, thus affording improved safety. 甘精胰岛素较中性鱼精蛋白锌胰岛素的主要优势是较少发生低血糖反应,从而具有较好的安全性。
As the basic insulin treatment, glarglne Was more efficient than NPH insulin. 作为基础胰岛素治疗,甘精胰岛素优于精蛋白锌胰岛素。
During a4-week lead-in, the subjects received premeal regular plus twice-daily NPH insulin. 在第一个4周期间,这些病人接受了一日两次的餐前规律中效胰岛素治疗。
Not for use with NPH insulin. 不能与NPH胰岛素的使用。
In many cases, constant basal insulin levels may be achieved with multiple overlapping doses of NPH insulin given together with short-acting insulin at mealtimes. 在许多病例中,一般胰岛素水平可通过在吃饭时重复给予中性鱼精蛋白锌胰岛素与短效胰岛素结合使用来实现。
Studies in type 1 diabetes found that, compared to NPH insulin or other conventional insulin therapy for type 1 diabetes, treatment with insulin glargine can improve the treatment satisfaction, total emotional well-being and total health well-being. 研究显示与中效胰岛素(NPH)或者一些其他1型糖尿病常用胰岛素治疗方案相比,甘精胰岛素的治疗可以改善1型和2型糖尿病患者的治疗满意度、总体情感和健康感觉。
Objective To compare the abilities and associated hypoglycemia risks of insulin glargine and human NPH insulin added to oral therapy of type 2 diabetes to achive HbAlc less than 7%. 目的在口服药物治疗的2型糖尿病病人中,比较加用甘精胰岛素或人NPH胰岛素使HbAlc达到7%的疗效和低血糖风险。
Methods: Instead of regular insulin and NPH treatment, 10 children with type 1 diabetes were treated with insulin aspart and NPH for one month, and the metabolic changes were observed. 方法:对10例应用诺和灵短效胰岛素联合诺和灵中效胰岛素治疗的1型糖尿病患儿以超短效胰岛素诺和锐等量替代短效胰岛素联合诺和灵中效胰岛素治疗1个月,观察HbA1c等代谢指标变化。